Xstrahl is a medical technology company that designs clinical and research systems to help eradicate cancer. For more than 30 years, Xstrahl has been shaping the development of superficial and orthovoltage therapies for cancer treatment and advancing pre-clinical research. Xstrahl systems are in operation at more than 700 treatment and research facilities worldwide.
Xstrahl superficial and orthovoltage systems deliver superior low-energy radiation treatment for skin cancer, providing maximum comfort to the patient without surgical risks. For skin cancer, low-energy treatments provide better clinical results for patients than conventional radiation therapy using a linear accelerators. Xstrahl low-energy radiation therapy systems are available in mobile and wall-mounted configurations and many different treatment energies (100 kV, 150kV, 200kV, 300kV) depending on the clinician’s needs and patient mix. Xstrahl cancer therapy systems are currently used at leading cancer therapy institutions worldwide.
Xstrahl offers both 3D X-ray irradiators and free standing systems to drive clinically relevant research forward with functionality and reproducibility. Xstrahl’s SARRP system is the first choice of radiation biology researchers worldwide due to its ability to mimic clinical radiation therapy using combination of high resolution CT imaging, dynamic couch and gantry movements, and intuitive treatment planning software. Xstrahl’s research cabinets are highly versatile, providing various depths and configurations with backing of an expert customer support team.
Press information contact: Adrian Treverton, CEO
Chief Executive Officer
Adrian had more than 10 years of industry leadership experience before coming to Xstrahl, as an International sales manager in 2006. As Sales Director, he took the lead on building up Xstrahl’s distributor network and growing the US subsidiary, ultimately moving to the USA in 2011 to continue his work with the Life Science brand. In 2013 Adrian was appointed Chief Operations Officer and continued to build a strong team around him. In 2017 after a management buy out Adrian was promoted to Group CEO.
Click below to download our corporate brochure.
Xstrahl Life Science